Table 3 Biochemical characteristics of renal function across tertiles of dietary antioxidant index in adults with type 2 diabetes referred to the Diabetes Research Center.

From: Association of dietary antioxidant indices with kidney function indicators in patients with type 2 diabetes: a cross-sectional study

 

Total Mean ± SD

Tertiles of DAI

p-value

T1

 < −6.97

N = 79

T2

− 6.97–0.37

N = 79

T3

 > 0.37

N = 79

BUN (mg/dL)

 crude

16.47 ± 7.34

16.89 ± 7.13

16.93 ± 6.03

15.66 ± 8.76

0.81

 Model I

16.47 ± 7.34

16.89 ± 7.13

16.93 ± 6.03

15.66 ± 8.76

0.05

 Model II

16.52 ± 7.45

16.89 ± 7.13

16.93 ± 6.18

15.78 ± 8.95

0.09

 Model III

16.52 ± 7.45

16.89 ± 7.13

16.93 ± 6.18

15.78 ± 8.95

0.16

Cr (mg/dL)

 crude

1.20 ± 2.90

1.06 ± 0.38

1.00 ± 0.32

1.57 ± 5.08

0.43

 Model I

1.21 ± 2.92

1.05 ± 0.38

1.00 ± 0.33

1.57 ± 5.08

0.59

 Model II

1.01 ± 0.31

1.03 ± 0.32

1.01 ± 0.33

0.98 ± 0.27

 < 0.001

 Model III

1.01 ± 0.31

1.03 ± 0.32

1.01 ± 0.33

0.98 ± 0.27

 < 0.001

Urea (mg/dL)

 crude

34.17 ± 13.98

35.33 ± 19.44

35.84 ± 11.06

31.23 ± 8.51

0.12

 Model I

34.13 ± 14.00

35.33 ± 19.44

35.73 ± 11.11

31.23 ± 8.51

0.002

 Model II

33.68 ± 11.76

34.07 ± 14.45

35.83 ± 11.04

30.97 ± 8.75

0.002

 Model III

33.68 ± 11.76

34.07 ± 14.45

35.83 ± 11.04

30.97 ± 8.75

0.005

GFR (mL/min/1.73m2)

 crude

78.98 ± 26.52

73.87 ± 22.02

77.52 ± 26.37

85.65 ± 29.68

0.04

 Model I

78.98 ± 26.52

73.87 ± 22.02

77.52 ± 26.37

85.65 ± 29.68

 < 0.001

 Model II

78.98 ± 26.46

74.16 ± 22.18

77.75 ± 26.53

85.16 ± 29.43

 < 0.001

 Model III

78.98 ± 26.46

74.16 ± 22.18

77.75 ± 26.53

85.16 ± 29.43

 < 0.001

  1. In model I variables were adjusted for Energy, age and gender.
  2. In model II Metformin, Atrovastatin, Novorpid, novomix, Lantus and Regular Insulin, Valsartan, Vitamins B1 and D3 and Folic Acid and Calcium D, Lasix, Plavix, Losartan, Zip Met, Rosovastatin, Rapaglinid, ziptin, levothyroxin, amlodioine, melijnet, glibenclamide, glutazone, ampagliflusion, Sostac, pregabalin, allopurinol, glorenta, carvedilol, metoral, empagent, aspirin, hydrochlorothiazide, gliclazide, spirinolacton , physical activity, Fast blood glucose, body mass index, smoking and comorbidities were adjusted, additionally.
  3. In model III fat, protein and fiber intakes were adjusted, additionally.
Back to article page